GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Trex Wind Down Inc (OTCPK:TMBRQ) » Definitions » 5-Year Dividend Growth Rate

Trex Wind Down (Trex Wind Down) 5-Year Dividend Growth Rate : 0.00% (As of Jun. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Trex Wind Down 5-Year Dividend Growth Rate?

Trex Wind Down's Dividends per Share for the three months ended in Jun. 2023 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Trex Wind Down's Dividend Payout Ratio for the three months ended in Jun. 2023 was 0.00. As of today, Trex Wind Down's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Trex Wind Down's 5-Year Dividend Growth Rate

For the Biotechnology subindustry, Trex Wind Down's 5-Year Dividend Growth Rate, along with its competitors' market caps and 5-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Trex Wind Down's 5-Year Dividend Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Trex Wind Down's 5-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Trex Wind Down's 5-Year Dividend Growth Rate falls into.


Trex Wind Down 5-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Trex Wind Down  (OTCPK:TMBRQ) 5-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Trex Wind Down's Dividend Payout Ratio for the quarter that ended in Jun. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jun. 2023 )/ EPS without NRI (Q: Jun. 2023 )
=0/ -1.265
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Trex Wind Down 5-Year Dividend Growth Rate Related Terms

Thank you for viewing the detailed overview of Trex Wind Down's 5-Year Dividend Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Trex Wind Down (Trex Wind Down) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Trex Wind Down Inc (OTCPK:TMBRQ) » Definitions » 5-Year Dividend Growth Rate
Comparable Companies
IMNN GRTX CMRA EVLO ONVO VYNE ARAV BNTC EDSA EIGR OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
3 Mountain View Road, Suite 100, Warren, NJ, USA, 07059
Website
https://www.timberpharma.com
Timber Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases. Its investigational therapies have mechanisms of action backed by decades of clinical experience and well-established CMC (chemistry, manufacturing, and control) and safety profiles. The company is focused on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis (CI), X-linked recessive CI (XLRI) and autosomal recessive CI (ARCI), and other sclerotic skin diseases. The company's late-stage program is TMB-001., and TMB-003 is the earliest-stage program.
Executives
John Koconis director, officer: Chief Executive Officer C/O TIMBER PHARMACEUTICALS, INC., 900 E. HAMILTON AVENUE, SUITE 100, CAMPBELL CA 95008
Alan Mendelsohn officer: Chief Medical Officer C/O TIMBER PHARMACEUTICALS, INC., 50 TICE BLVD., SUITE A26, WOODCLIFF LAKE NJ 07677
Edward J Sitar director 39 FLAMING ARROW ROAD, MAHWAH NJ 07430
Tardimed Sciences Llc 10 percent owner 303 SOUTH BROADWAY, SUITE 125, TARRYTOWN NY 10591
David E Cohen director 3160 PORTER DRIVE, PALO ALTO CA 94304
Lubor Gaal director C/O TIMBER PHARMACEUTICALS, INC., 900 E. HAMILTON AVENUE, SUITE 100, CAMPBELL CA 95008
Kimberly Bragg officer: Controller C/O TIMBER PHARMACEUTICALS, INC., 900 E. HAMILTON AVENUE, SUITE 100, CAMPBELL CA 95008
Amir Tavakkol officer: Chief Scientific Officer C/O VIAMET PHARMACEUTICALS HOLDINGS LLC, 4505 EMPEROR BLVD., SUITE 300, DURHAM NC 27703
Michael Derby director, officer: Executive Chairman 303 SOUTH BROADWAY, SUITE 125, TARRYTOWN NY 10591
Zachary Rome director, officer: Executive VP, COO and Sec. C/O TIMBER PHARMACEUTICALS, INC., 900 E. HAMILTON AVENUE, SUITE 100, CAMPBELL CA 95008
Joseph Lucchese officer: Executive VP & CFO C/O TIMBER PHARMACEUTICALS, INC., 900 E. HAMILTON AVENUE, SUITE 100, CAMPBELL CA 95008
Michael Stocum director C/O TIMBER PHARMACEUTICALS, INC., 900 E. HAMILTON AVENUE, SUITE 100, CAMPBELL CA 95008
Linda A Broenniman director 1895 PRESTON WHITE DR, STE 250, RESTON VA 20191
Gianluca Pirozzi director C/O TIMBER PHARMACEUTICALS, INC., 900 E. HAMITON AVENUE, SUITE 100, CAMPBELL CA 95008
Timber Pharmaceuticals Llc 10 percent owner 50 TICE BOULEVARD, SUITE A26, WOODCLIFF LAKE NJ 07677